المؤلفون: Lévy, Yves, Lelièvre, Jean-Daniel, Assoumou, Lambert, Aznar, Esther, Pulido, Federico, Tambussi, Giuseppe, Crespo, Manuel, Meybeck, Agnès, Molina, Jean-Michel, Delaugerre, Constance, Izopet, Jacques, Peytavin, Gilles, Cardon, Fanny, Diallo, Alpha, Lancar, Rémi, Béniguel, Lydie, Costagliola, Dominique

المساهمون: Vaccine Research Institute (VRI), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica = Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Hospital Universitario 12 de Octubre [Madrid], Universidad Complutense de Madrid = Complutense University of Madrid [Madrid] (UCM), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS San Raffaele Pisana), Vall d'Hebron University Hospital [Barcelona], Centre Hospitalier de Tourcoing, Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre de Physiopathologie Toulouse Purpan (CPTP), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), CHU Toulouse [Toulouse], AP-HP - Hôpital Bichat - Claude Bernard [Paris], Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS)

المصدر: Annals of Internal Medicine
Annals of Internal Medicine, American College of Physicians, 2020, 172 (5), pp.297-305. ⟨10.7326/M19-2133⟩

مصطلحات موضوعية: MESH: Viral Load / drug effects, MESH: Agents / administration & dosage, MESH: Humans, MESH: Middle Aged, MESH: CD4 Lymphocyte Count, MESH: Maraviroc / therapeutic use, MESH: Adult, MESH: HIV-1 / drug effects, MESH: HIV Fusion Inhibitors / administration & dosage, MESH: Male, MESH: Aged Anti-HIV, MESH: Anti-HIV Agents / therapeutic use, MESH: Young Adult, MESH: Antiretroviral Therapy, Highly Active / methods, MESH: HIV Infections / drug therapy, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, MESH: HIV Fusion Inhibitors / therapeutic use, MESH: Double-Blind Method, MESH: Female, MESH: Maraviroc / administration & dosage, MESH: Treatment Outcome

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______4325::373c10ef5347e3e82082d01fcacfc7e0
https://ut3-toulouseinp.hal.science/hal-03578146

المساهمون: Yu, Xiyao., Chinese University of Hong Kong Graduate School. Division of Life Sciences.

مصطلحات موضوعية: AIDS (Disease)--Chemotherapy, HIV infections--Chemotherapy, Drug resistance, Acquired Immunodeficiency Syndrome--drug therapy, HIV Infections--drug therapy, HIV Fusion Inhibitors--therapeutic use

وصف الملف: electronic resource; remote; 1 online resource (xi, 107 leaves) : ill. (some col.)

Relation: cuhk:328701; http://library.cuhk.edu.hk/record=b5549184; https://repository.lib.cuhk.edu.hk/en/item/cuhk-328701

الاتاحة: http://library.cuhk.edu.hk/record=b5549184
https://repository.lib.cuhk.edu.hk/en/item/cuhk-328701

المؤلفون: Borrego, P, Calado, R, Marcelino, JM, Bártolo, I, Rocha, C, Cavaco-Silva, P, Doroana, M, Antunes, F, Maltez, F, Caixas, U, Barroso, H, Taveira, N

مصطلحات موضوعية: HSJ MED, HCC INF, Amides/pharmacology, Amides/therapeutic use, Anti-HIV Agents/pharmacology, Anti-HIV Agents/therapeutic use, CCR5 Receptor Antagonists, Cyclohexanes/pharmacology, Cyclohexanes/therapeutic use, HIV Envelope Protein gp41/pharmacology, HIV Envelope Protein gp41/therapeutic use, HIV Fusion Inhibitors/pharmacology, HIV Fusion Inhibitors/therapeutic use, HIV Infections/drug therapy, HIV Infections/virology, HIV-1/drug effects, HIV-2/drug effects, Inhibitory Concentration 50, Microbial Sensitivity Tests, Peptide Fragments/pharmacology, Peptide Fragments/therapeutic use, Quaternary Ammonium Compounds/pharmacology, Quaternary Ammonium Compounds/therapeutic use, Triazoles/pharmacology, Triazoles/therapeutic use

Relation: Antivir Ther. 2012;17(3):565-70; http://hdl.handle.net/10400.17/2417

الاتاحة: http://hdl.handle.net/10400.17/2417
https://doi.org/10.3851/IMP1996

المؤلفون: Flamholc, L

المصدر: Incitament. 17(7):414

المؤلفون: Lagercrantz, S

المصدر: Läkemedelsvärlden. 111(4):16

المصدر: 2019 , ' Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy : Results from a randomised clinical trial ' , International Journal of Antimicrobial Agents , vol. 54 , no. 5 , pp. 592-600 . https://doi.org/10.1016/j.ijantimicag.2019.08.001

مصطلحات موضوعية: Antiretroviral Therapy, Highly Active, Antirheumatic Agents/therapeutic use, Auranofin/therapeutic use, CD4 Lymphocyte Count, DNA, Viral/drug effects, HIV Fusion Inhibitors/therapeutic use, HIV Infections/drug therapy, HIV Integrase Inhibitors/therapeutic use, HIV-1/drug effects, Heterocyclic Compounds, 3-Ring/therapeutic use, Humans, Maraviroc/therapeutic use, Oxazines, Piperazines, Proviruses/drug effects, Pyridones, Virus Latency/drug effects

الاتاحة: https://hdl.handle.net/1983/d4e3ba17-387b-497a-9039-b3ab59c421cc
https://research-information.bris.ac.uk/en/publications/d4e3ba17-387b-497a-9039-b3ab59c421cc
https://doi.org/10.1016/j.ijantimicag.2019.08.001

المؤلفون: Cheila Rocha, Fernando Maltez, Umbelina Caixas, Pedro Borrego, Manuela Doroana, Patrícia Cavaco-Silva, Rita Calado, Inês Bártolo, Francisco Antunes, Helena Barroso, José Maria Marcelino, Nuno Taveira

المصدر: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP

مصطلحات موضوعية: Male, Cyclohexanes/pharmacology, Enfuvirtide, HIV Fusion Inhibitors/pharmacology, HCC INF, Human immunodeficiency virus (HIV), HIV Infections, Cyclohexanes/therapeutic use, medicine.disease_cause, Maraviroc, HIV Envelope Protein gp41/therapeutic use, chemistry.chemical_compound, HIV Fusion Inhibitors, inhibitors, Medicine, Pharmacology (medical), Triazoles/pharmacology, HIV Fusion Inhibitors/therapeutic use, Antiviral therapy, virus diseases, HIV Envelope Protein gp41/pharmacology, HIV Envelope Protein gp41, HIV-2/drug effects, Infectious Diseases, HIV-1/drug effects, Publishing, CCR5 Receptor Antagonists, Female, Triazoles/therapeutic use, medicine.drug, medicine.medical_specialty, Amides/therapeutic use, Anti-HIV Agents, HIV Infections/drug therapy, MEDLINE, Microbial Sensitivity Tests, Inhibitory Concentration 50, Cyclohexanes, HSJ MED, Anti-HIV Agents/pharmacology, Humans, Inhibitory concentration 50, Baseline (configuration management), Amides/pharmacology, Pharmacology, Peptide Fragments/therapeutic use, Quaternary Ammonium Compounds/therapeutic use, Peptide Fragments/pharmacology, Quaternary Ammonium Compounds/pharmacology, business.industry, Triazoles, Amides, Virology, Peptide Fragments, Quaternary Ammonium Compounds, chemistry, Anti-HIV Agents/therapeutic use, Family medicine, HIV-2, HIV-1, HIV Infections/virology, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5436ab91c7957e9b24f768dbac3da4fd
https://doi.org/10.3851/imp1996

المؤلفون: Michel Segondy, Christine Katlama, Nadine Ktorza, Jean-Claude Piot, Luc Perrin, Jacques Reynes, Anne-Geneviève Marcelin, Sabine Yerly, Laurent Kaiser, Jean-François Delfraissy, Vincent Calvez

المصدر: AIDS, Vol. 18, No 9 (2004) pp. 1340-1342

مصطلحات موضوعية: Genes, Viral, Immunology, Population, Salvage therapy, HIV Infections, Viremia, Enfuvirtide, Biology, Virus, HIV Envelope Protein gp41/ genetics/therapeutic use, HIV Fusion Inhibitors, Drug Resistance, Viral, Genotype, medicine, Humans, Immunology and Allergy, Treatment Failure, education, Sida, ddc:616, Peptide Fragments/therapeutic use, education.field_of_study, HIV Infections/drug therapy/ virology, Hiv-1, HIV Fusion Inhibitors/therapeutic use, Sequence Analysis, DNA, biology.organism_classification, medicine.disease, Virology, HIV Envelope Protein gp41, Peptide Fragments, Protein Structure, Tertiary, Infectious Diseases, Mutation, Lentivirus, HIV-1, Viral disease

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bef9327c0d4ba6c725fae2a1c563750
https://doi.org/10.1097/00002030-200406180-00015

المؤلفون: Marcelin, A. G., Reynes, Jacques, Yerly Ferrillo, Sabine, Ktorza, Nadine, Segondy, Michel, Piot, J. C., Delfraissy, J. F., Kaiser, Laurent, Perrin, Luc, Katlama, Christine, Calvez, Vincent

المصدر: ISSN: 0269-9370 ; AIDS, vol. 18, no. 9 (2004) p. 1340-1342.

مصطلحات موضوعية: info:eu-repo/classification/ddc/616, Drug Resistance, Viral, Genes, HIV Envelope Protein gp41/ genetics/therapeutic use, HIV Fusion Inhibitors/therapeutic use, HIV Infections/drug therapy/ virology, Hiv-1, Humans, Mutation, Peptide Fragments/therapeutic use, Protein Structure, Tertiary, Sequence Analysis, DNA, Treatment Failure

Relation: info:eu-repo/semantics/altIdentifier/pmid/15362669; https://archive-ouverte.unige.ch/unige:7424; unige:7424

الاتاحة: https://archive-ouverte.unige.ch/unige:7424

المؤلفون: Este, J. A., Telenti, A.

المصدر: Lancet, vol. 370, no. 9581, pp. 81-8

مصطلحات موضوعية: Anti-HIV Agents/classification/*therapeutic use Clinical Trials HIV Envelope Protein gp41/*therapeutic use HIV Fusion Inhibitors/*therapeutic use HIV Infections/*prevention & control HIV-1/*physiology Heterocyclic Compounds/*therapeutic use Humans Peptide Fragments/*therapeutic use Receptors, CCR5/*antagonists & inhibitors Virus Replication/*drug effects

Relation: info:eu-repo/semantics/altIdentifier/pmid/17617275; info:eu-repo/semantics/altIdentifier/eissn/1474-547X; https://serval.unil.ch/notice/serval:BIB_1AC21802D15B

الاتاحة: https://serval.unil.ch/notice/serval:BIB_1AC21802D15B
https://doi.org/10.1016/S0140-6736(07)61052-6